Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploration of Novel Antimicrobial Peptides from Gut Probiotics Enterococcus spp. Against Extensively drug-resistant Pathogens Through cutting-edge Computational Discovery.

Probiotics and antimicrobial proteins·2026
Same author

Enhancement of the efficiency of a DNA vaccine construct harboring HSP70 mini-chaperones linked to HIV-1 Nef antigen using IL-7 cytokine and REV peptide.

Microbial pathogenesis·2026
Same author

Simultaneous efficacy of IL-15 and the HSP70 fragments in increasing immunostimulatory effects of a HIV-1 DNA vaccine candidate against SCR HIV-1.

PloS one·2025
Same author

From simulation to immunization: efficient non-viral delivery of HIV-1 Nef<sup>mut</sup>-Tat DNA construct using CM18-TAT11 cell penetrating peptide.

International journal of pharmaceutics·2025
Same author

In Silico Analysis of Tat Exons to Increase the Efficacy of a Nef-Tat-based HIV-1 Vaccine Candidate.

Iranian journal of pharmaceutical research : IJPR·2025
Same author

Investigation of synergistic effects of β-defensin, vesatolimod and resiquimod in increasing the potency of a therapeutic HIV-1 vaccine candidate.

Journal of pharmaceutical sciences·2025

Related Experiment Video

Updated: May 14, 2026

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery
06:37

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Published on: October 18, 2012

DNA immunization as an efficient strategy for vaccination.

Azam Bolhassani1, Sima Rafati Yazdi

  • 1Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran.

Avicenna Journal of Medical Biotechnology
|February 15, 2013
PubMed
Summary

DNA vaccines show promise for controlling diseases but need enhanced potency for human use. Strategies like antigen linkage to heat shock proteins (HSPs) and improved delivery systems boost DNA vaccine effectiveness in animal models.

Keywords:
AdjuvantDNA vaccinationDelivery systemInfectious diseasePrime-boost vaccination

More Related Videos

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Related Experiment Videos

Last Updated: May 14, 2026

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery
06:37

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Published on: October 18, 2012

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Area of Science:

  • Vaccinology
  • Immunology
  • Molecular Biology

Background:

  • Genetic immunization using naked DNA effectively induces humoral and cellular immune responses.
  • DNA vaccines hold significant potential for preventing infectious diseases, cancer, autoimmune disorders, and allergies.
  • Despite pre-clinical success, DNA vaccines have shown insufficient potency in human trials.

Purpose of the Study:

  • To review recent advancements in enhancing the efficiency of DNA vaccination in animal models.
  • To discuss strategies for overcoming the limitations of DNA vaccine potency in clinical applications.

Main Methods:

  • Exploring antigen linkage to Heat Shock Proteins (HSPs) to improve DNA vaccine efficacy.
  • Investigating physical delivery methods and microparticle formulations for enhanced DNA vaccine uptake by Antigen-Presenting Cells (APCs).
  • Examining prime-boost vaccination regimens utilizing naked DNA followed by viral vectors or recombinant proteins with adjuvants.

Main Results:

  • Linking antigens to HSPs and employing advanced delivery systems are effective strategies for increasing DNA vaccine potency.
  • Physical delivery and microparticle formulations improve antigen production and APC targeting in animal models.
  • Prime-boost vaccination strategies demonstrate enhanced immune responses.

Conclusions:

  • Significant progress has been made in upgrading DNA vaccine efficiency in animal models.
  • Further research and application of these strategies are crucial for translating DNA vaccine success to human clinical settings.
  • Optimizing DNA vaccine delivery and formulation holds the key to achieving protective immunity in humans.